BeiGene, Ltd.

NasdaqGS:BGNE Stok Raporu

Piyasa değeri: US$24.8b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

BeiGene Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

John Oyler

İcra Kurulu Başkanı

US$18.9m

Toplam tazminat

CEO maaş yüzdesi4.6%
CEO görev süresi14.8yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi2.5yrs
Yönetim Kurulu ortalama görev süresi4.5yrs

Son yönetim güncellemeleri

Recent updates

BeiGene: Poised For Re-Rating As BTKi Sales Show Strong Beat

Aug 22

Analysts Just Made An Incredible Upgrade To Their BeiGene, Ltd. (NASDAQ:BGNE) Forecasts

Aug 14
Analysts Just Made An Incredible Upgrade To Their BeiGene, Ltd. (NASDAQ:BGNE) Forecasts

BeiGene, Ltd. (NASDAQ:BGNE) Shares Fly 27% But Investors Aren't Buying For Growth

Aug 09
BeiGene, Ltd. (NASDAQ:BGNE) Shares Fly 27% But Investors Aren't Buying For Growth

BeiGene: Navigating Patent Disputes Towards Profitability (Rating Upgrade)

Jun 21

We Think Some Shareholders May Hesitate To Increase BeiGene, Ltd.'s (NASDAQ:BGNE) CEO Compensation

May 30
We Think Some Shareholders May Hesitate To Increase BeiGene, Ltd.'s (NASDAQ:BGNE) CEO Compensation

Is BeiGene (NASDAQ:BGNE) Using Too Much Debt?

Apr 21
Is BeiGene (NASDAQ:BGNE) Using Too Much Debt?

BeiGene Still Bleeding Red Ink Despite Blockbuster Drug

Mar 08

BeiGene, Ltd.'s (NASDAQ:BGNE) Intrinsic Value Is Potentially 26% Above Its Share Price

Jan 31
BeiGene, Ltd.'s (NASDAQ:BGNE) Intrinsic Value Is Potentially 26% Above Its Share Price

Here's Why BeiGene (NASDAQ:BGNE) Can Manage Its Debt Despite Losing Money

Oct 16
Here's Why BeiGene (NASDAQ:BGNE) Can Manage Its Debt Despite Losing Money

Is There An Opportunity With BeiGene, Ltd.'s (NASDAQ:BGNE) 39% Undervaluation?

Jul 11
Is There An Opportunity With BeiGene, Ltd.'s (NASDAQ:BGNE) 39% Undervaluation?

Rock star Growth Puts BeiGene (NASDAQ:BGNE) In A Position To Use Debt

Jun 19
Rock star Growth Puts BeiGene (NASDAQ:BGNE) In A Position To Use Debt

Revenues Not Telling The Story For BeiGene, Ltd. (NASDAQ:BGNE)

Apr 17
Revenues Not Telling The Story For BeiGene, Ltd. (NASDAQ:BGNE)

A Look At The Fair Value Of BeiGene, Ltd. (NASDAQ:BGNE)

Mar 24
A Look At The Fair Value Of BeiGene, Ltd. (NASDAQ:BGNE)

CEO Tazminat Analizi

John Oyler'un ücretlendirmesi BeiGene'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$524m

Mar 31 2024n/an/a

-US$784m

Dec 31 2023US$19mUS$871k

-US$882m

Sep 30 2023n/an/a

-US$959m

Jun 30 2023n/an/a

-US$2b

Mar 31 2023n/an/a

-US$2b

Dec 31 2022US$18mUS$800k

-US$2b

Sep 30 2022n/an/a

-US$2b

Jun 30 2022n/an/a

-US$2b

Mar 31 2022n/an/a

-US$2b

Dec 31 2021US$17mUS$740k

-US$1b

Sep 30 2021n/an/a

-US$1b

Jun 30 2021n/an/a

-US$1b

Mar 31 2021n/an/a

-US$1b

Dec 31 2020US$14mUS$696k

-US$2b

Sep 30 2020n/an/a

-US$2b

Jun 30 2020n/an/a

-US$1b

Mar 31 2020n/an/a

-US$1b

Dec 31 2019US$13mUS$675k

-US$949m

Sep 30 2019n/an/a

-US$829m

Jun 30 2019n/an/a

-US$665m

Mar 31 2019n/an/a

-US$737m

Dec 31 2018US$28mUS$650k

-US$674m

Sep 30 2018n/an/a

-US$505m

Jun 30 2018n/an/a

-US$243m

Mar 31 2018n/an/a

-US$147m

Dec 31 2017US$10mUS$515k

-US$93m

Tazminat ve Piyasa: John 'nin toplam tazminatı ($USD 18.93M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 13.04M ).

Tazminat ve Kazançlar: John şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

John Oyler (56 yo)

14.8yrs

Görev süresi

US$18,925,730

Tazminat

Mr. John V. Oyler Co-Founded BeiGene, Ltd. and has been its Chief Executive Officer since 2010. Mr. Oyler Co-founded BioDuro, LLC and served as its Chief Executive Officer and President from 2005 to 2009....

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
John Oyler
Co-Founder14.8yrsUS$18.93mVeri yok
Xiaobin Wu
President & COO6.4yrsUS$11.00mVeri yok
Xiaodong Wang
Co-Chairman of Scientific Advisory Board & Non-Executive Director and Co-Founder14.8yrsUS$4.42mVeri yok
Chan Lee
General Counsel & Senior VP2.3yrsUS$4.05mVeri yok
Wang Lai
Global Head of R&Dno dataUS$7.32mVeri yok
Aaron Rosenberg
CFO & Principal Financial Officerless than a yearVeri yokVeri yok
Titus Ball
VP & Chief Accounting Officerless than a yearVeri yokVeri yok
Liza Heapes
Head of Investor Relationsno dataVeri yokVeri yok
Yang Ji
Chief Compliance Officerless than a yearVeri yokVeri yok
Yan Qi
Senior VP & Head of Public Affairs - Greater China3.8yrsVeri yokVeri yok
Jason Radford
Senior Vice President of Strategy & Corporate Development1.7yrsVeri yokVeri yok
Mark Lanasa
Senior VP & Chief Medical Officer for Solid Tumors2.7yrsVeri yokVeri yok

2.5yrs

Ortalama Görev Süresi

53.5yo

Ortalama Yaş

Deneyimli Yönetim: BGNE 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.5 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
John Oyler
Co-Founder14yrsUS$18.93mVeri yok
Xiaodong Wang
Co-Chairman of Scientific Advisory Board & Non-Executive Director and Co-Founder8.7yrsUS$4.42mVeri yok
Steven Young
Acting Head of Medicinal Chemistry & Member of Scientific Advisory Board3.5yrsVeri yokVeri yok
Michael Goller
Independent Non-Executive Director & Member of the Scientific Advisory Committee9.5yrsUS$481.92kVeri yok
Donald Glazer
Independent Non-Executive Director11.7yrsUS$480.80kVeri yok
Corazon Sanders
Independent Non-Executive Director & Member of Scientific Advisory Committee4.2yrsUS$501.55kVeri yok
Anthony Hooper
Independent Non-Executive Director4.8yrsUS$513.15kVeri yok
Shalini Sharp
Directorless than a yearVeri yokVeri yok
Alessandro Riva
Co-Chairman of Scientific Advisory Committee & Independent Non-Executive Director2.7yrsUS$491.67kVeri yok
Olivier Brandicourt
Independent Non-Executive Directorless than a yearVeri yok0%
$ 0
Ranjeev Krishana
Independent Lead Director10yrsUS$487.05kVeri yok
Margaret Han Dugan
Member of Scientific Advisory Board & Independent Non-Executive Director2.7yrsUS$510.55kVeri yok

4.5yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: BGNE 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.5 yıldır).